Selling And Administration Expenses Changement
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Amarin AMRN:US 86.89M 3.75M
Amgen AMGN:US $ 1.33B 99M
AstraZeneca AZN:LN 3.27B 209M
Bayer BAYN:GR 4.47B 527M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bluebird Bio BLUE:US $ 36.69M 588K
Exelixis EXEL:US $ 122.76M 19.9M
Fresenius Medical Care FME:GR 969M 97.76M
Galapagos GLPG:NA 71.67M 9.33M
Genmab GEN:DC 452M 60M
GlaxoSmithKline GSK:LN 1.96B 726M
GN Store Nord GN:DC 1.36B 85M
Hikma Pharmaceutical HIK:LN 256M 0
Immunogen IMGN:US $ 23.79M 7.14M
Insmed INSM:US $ 59.97M 3.23M
Merck MRK:GR 1.52B 151M
Novartis NOVN:VX 3.59B 91M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Seattle Genetics SGEN:US $ 220.26M 46.03M
William Demant Holding WDH:DC 4.64B 158M



Genmab Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2022.